NEW YORK (GenomeWeb News) – Platypus Technologies will use a $100,000 grant from the National Institutes of Health to develop its cell motility products for use in high-throughput screening applications, the firm said on Tuesday.

The one-year Small Business Innovation Research grant will support an expansion of and modifications to the current Oris 96-well cell migration assay in order to make it compatible with automated liquid handling and high content imaging systems.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.